Zaika Oleg, Tolstykh Gleb P, Jaffe David B, Shapiro Mark S
Department of Physiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA.
J Neurosci. 2007 Aug 15;27(33):8914-26. doi: 10.1523/JNEUROSCI.1739-07.2007.
Purinergic P2Y receptors are one of four types of G(q/11)-coupled receptors in rat superior cervical ganglia (SCG) sympathetic neurons. In cultured SCG neurons, purinergic and bradykinin suppression of I(M) were similar in magnitude and somewhat less than that by muscarinic agonists. The effects of the P2Y receptor agonist UTP on neuronal excitability and discharge properties were studied. Under current clamp, UTP increased action potential (AP) firing in response to depolarizing current steps, depolarized the resting potential, decreased the threshold current required to fire an AP, and decreased spike-frequency adaptation. These effects were very similar to those resulting from bradykinin stimulation and not as profound as from muscarinic stimulation or full M-current blockade. We then examined the P2Y mechanism of action. Like bradykinin, but unlike muscarinic, purinergic stimulation induced rises in intracellular Ca(2+). Tests using expression of IP(3)"sponge" or IP(3) phosphatase constructs implicated IP(3) accumulation as necessary for purinergic suppression of I(M). Overexpression of wild-type or dominant-negative calmodulin (CaM) implicated Ca(2+)/CaM in the purinergic action. Both sets of results were similar to bradykinin, and opposite to muscarinic, suppression. We also examined modulation of Ca(2+) channels. As for bradykinin, purinergic stimulation did not suppress I(Ca), unless neuronal calcium sensor-1 (NCS-1) activity was blocked by a dominant-negative NCS-1 construct. Our results indicate that P2Y receptors modulate M-type channels in SCG cells via IP(3)-mediated Ca(2+) signals in concert with CaM and not by depletion of phosphatidylinositol-4, 5-biphosphate. We group purinergic P2Y and bradykinin B(2) receptors together as having a common mode of action.
嘌呤能P2Y受体是大鼠颈上神经节(SCG)交感神经元中四种G(q/11)偶联受体类型之一。在培养的SCG神经元中,嘌呤能和缓激肽对I(M)的抑制在程度上相似,且略小于毒蕈碱激动剂的抑制作用。研究了P2Y受体激动剂UTP对神经元兴奋性和放电特性的影响。在电流钳制下,UTP增加了对去极化电流阶跃的动作电位(AP)发放,使静息电位去极化,降低了引发AP所需的阈电流,并减少了峰频率适应性。这些效应与缓激肽刺激产生的效应非常相似,不如毒蕈碱刺激或完全M电流阻断产生的效应那么显著。然后我们研究了P2Y的作用机制。与缓激肽一样,但与毒蕈碱不同,嘌呤能刺激导致细胞内[Ca(2+)](i)升高。使用IP(3)“海绵”或IP(3)磷酸酶构建体的表达进行的测试表明,IP(3)积累是嘌呤能抑制I(M)所必需的。野生型或显性负性钙调蛋白(CaM)的过表达表明Ca(2+)/CaM参与了嘌呤能作用。这两组结果都与缓激肽相似,与毒蕈碱抑制相反。我们还研究了Ca(2+)通道的调节。与缓激肽一样,嘌呤能刺激不会抑制I(Ca),除非神经元钙传感器-1(NCS-1)活性被显性负性NCS-1构建体阻断。我们的结果表明,P2Y受体通过IP(3)介导的[Ca(2+)](i)信号与CaM协同调节SCG细胞中的M型通道,而不是通过磷脂酰肌醇-4,5-二磷酸的消耗。我们将嘌呤能P2Y受体和缓激肽B(2)受体归为具有共同作用模式的一类。